Furthermore, the survival data from the Kaplan–Meier survival analysis of distant metastasis-free survival (DMFS) breast cancer patients with metastatic disease suggested that breast cancer patients with higher ANKRD1 expression have lower survival rates. The gene discussed is ANKRD1; the disease is metastatic neoplasm.